Artara Therapeutics Inc (TARA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -33,978 | -7,830 | -20,729 | -29,964 | -28,526 |
| Depreciation Amortization | 103 | 16 | 64 | 146 | 254 |
| Other Working Capital | 722 | 2,379 | -5,972 | 4,412 | 1,293 |
| Other Operating Activity | 9,746 | 424 | 3,404 | 3,054 | 3,292 |
| Operating Cash Flow | $-23,407 | $-5,011 | $-23,233 | $-22,352 | $-23,687 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | -15,443 | -32,942 | -39,756 |
| PPE Investments | -884 | -475 | -119 | -35 | -271 |
| Sale Of Investment | N/A | N/A | 33,989 | 16,878 | 59,943 |
| Other Investing Activity | 3,719 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $2,835 | $-475 | $18,427 | $-16,099 | $19,916 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 500 | N/A | N/A | N/A |
| Debt Issued | 11,087 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 530 | N/A | 2,985 | 1,526 | 208 |
| Other Financing Activity | 177,784 | 0 | 0 | 21,523 | 0 |
| Financing Cash Flow | $189,401 | $500 | $2,985 | $23,049 | $208 |
| Exchange Rate Effect | N/A | N/A | 22 | 180 | -76 |
| Beginning Cash Position | 564 | 5,550 | 21,192 | 36,414 | 40,045 |
| End Cash Position | 169,393 | 564 | 19,393 | 21,192 | 36,406 |
| Net Cash Flow | $168,829 | $-4,986 | $-1,799 | $-15,222 | $-3,639 |
| Free Cash Flow | |||||
| Operating Cash Flow | -23,407 | -5,011 | -23,233 | -22,352 | -23,687 |
| Capital Expenditure | -884 | -475 | -119 | -35 | -271 |
| Free Cash Flow | -24,291 | -5,486 | -23,352 | -22,387 | -23,958 |